Walleye Trading’s Regenxbio RGNX Stock Holding History

Walleye Trading’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-319	Closed	-$11.9K	–	4546
2020 Q1	$10K	Buy	+319	New	+$13.3K	﹤0.01%	3723
2018 Q4	–	Sell	-894	Closed	-$67K	–	5193
2018 Q3	$67K	Buy	+894	New	+$64.4K	﹤0.01%	4428

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Walleye Trading's RGNX Position: Q2 2020 in Review

Walleye Trading sold out of Regenxbio (RGNX) in Q2 2020, closing a stake of 319 shares — an estimated $11.9K sold.

Walleye Trading first reported a position in RGNX in Q3 2018 and held it in 2 quarters. The position peaked at $67K in Q3 2018. 179 funds tracked by Wall St. Rank hold RGNX as of Q2 2020.

Walleye Trading reported no remaining Regenxbio position as of Q2 2020 after selling out during the quarter.
Walleye Trading sold 319 Regenxbio shares in Q2 2020, an estimated $11.9K.
Walleye Trading first reported a position in Regenxbio in Q3 2018 and held it in 2 quarters.
Walleye Trading's Regenxbio position peaked at $67K in Q3 2018.
179 funds tracked by Wall St. Rank held Regenxbio as of Q2 2020.

Based on Walleye Trading's 13F filing for Q2 2020, filed 14 Aug 2020.